3D Sys Sees Q3 Sales $96.000M-$99.000M vs $93.787M Est

Correction: Bioprinting Market to Reach $5.1 Billion by 2030, Driven by Regenerative Medicine Demand and AI Integration

The global bioprinting market is projected to grow from $2.1 billion in 2024 to $5.1 billion by 2030 at a 16.1% CAGR, driven by regenerative medicine demand, pharmaceutical adoption for drug discovery, reduced animal testing, and AI integration. North America leads with 38% market share, while emerging technologies like 4D bioprinting and organ-on-chip devices expand market boundaries.

3D Systems Enters Into CRADA With Savannah River National Laboratory To Accelerate Innovation In AM For Advanced Energy Generation And National Security Applications

New CRADA drives joint development of advanced materials, AI/ML process optimization, equipment enhancements, and scalable production solutionsPositions additive manufacturing to support nuclear energy systems, energy

3D Systems Announces Additional $9M Air Force Award For Large-Format Metal 3D Printer Demonstrator Program, Extending It Two Years And Lifting Total Funding To $27.4M

Full Transcript: 3D Sys Q2 2026 Earnings Call

3D Sys (NYSE:DDD) released second-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data and